Ocuphire Pharma Investor Day Presentation Deck
108
Ocuphire Management Team
Decades of Biotech and Drug Development Experience
POINT GUARD
PARTNERS LLC
Ronil Patel, MS
Senior Director BD and
Market Strategy
FLORIDA TECH
BETALIO Revitalid
MERCK
Bindu Manne
Head, Market Development
and Commercialization
'UNC
PEMBROKI
Ocularis Pharma
Prudential
Syber Goldman
DevBx
Sachs
OCULOS
Integrated Insight.
Therapeutix"
1 ThromboGenics®
Charlie Hoffmann, MBA
VP Corporate Development
and Operations
Takeda
Shire
Tuck School of Business
IIIII at Dartmouth
1900
equinox
Daniela Oniciu, PhD
Global Head, R&D, Chemistry
and Product Development
UNIVERSITY of
UF
Gemphire ESPERION
Cerenis™ Pfizer
THERAPEUTICS
aerpio
Gemphire
Therapeutics
MONITOR ProNAI
Chris Ernst
Global Head, QA
and Manufacturing
NORTHERN
KENTUCKY
UNIVERSITY
Akebia
THERAPEUTICS
VE DI ES
MEDPACE
Mina Sooch, MBA
President & CEO
and Founder
HARVARD
BUSINESS SCHOOL
Apjohn
Ventures
MIMICHIGAN ROSS
Pfizer
Gemphire
Therapeutics
NeuroBo
PHARMACEUTICALS
Mitch Brigell, PhD
Head, Clinical Development
and Strategy
KANSAS STATE
aerpio
& NOVARTIS
Amy Rabourn, CPA
VP, Finance
UNIVERSITY
Pfizer
Laura Gambino
Director, Project Management
EASTERN
MICHIGAN UNIVERSITY
aerpio Akebia Pfizer
THERAPEUTICS
pwc
Barbara Withers, PhD
VP, Clinical and
Regulatory Strategy
SIRION
Therapeutics
WAYNE STATE
UNIVERSITY
SCHOOL OF MEDICINE
GE
aerpio GUBC Pfizer
Drey Coleman
VP, Clinical Operations
OCULOS
Integrated Insight.
UCF
Ocuphire
PHARMAView entire presentation